Cargando…
Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest
Cisplatin (CDDP) and its derivatives are first line anti-cancer drugs for ovarian cancer (OVCA). However, chemoresistance due to high incidence of p53 mutations leads to poor clinical prognosis. Saikosaponin-d (Ssd), a saponin from a herbal plant extract, has been shown to induce cell death and sens...
Autores principales: | Tsuyoshi, Hideaki, Wong, Vincent Kam Wai, Han, Yu, Orisaka, Makoto, Yoshida, Yoshio, Tsang, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725134/ https://www.ncbi.nlm.nih.gov/pubmed/29245943 http://dx.doi.org/10.18632/oncotarget.21076 |
Ejemplares similares
-
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020) -
The role of pituitary gonadotropins and intraovarian regulators in follicle development: A mini‐review
por: Orisaka, Makoto, et al.
Publicado: (2021) -
Evaluation of calcification distribution by CT-based textural analysis for discrimination of immature teratoma
por: Nakamori, Akari, et al.
Publicado: (2023) -
Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging
por: Isaji, Yuzu, et al.
Publicado: (2023) -
Attitudes toward cancer screening in regional Japan during the COVID‐19 pandemic: An anonymous survey
por: Inoue, Daisuke, et al.
Publicado: (2023)